Testing effectiveness (Phase 2)Ended earlyNCT00073476What this trial is testingEvaluate the Efficacy and Safety of CP-101,606 in Subjects With an Acute StrokeWho this might be right forStroke Pfizer 300
Testing effectiveness (Phase 2)Study completedNCT04091945What this trial is testingEvaluate the Safety and Potential Efficacy of LT3001 Drug Product in Subjects With AISWho this might be right forAcute Ischemic Stroke Lumosa Therapeutics Co., Ltd. 24
Large-scale testing (Phase 3)Ended earlyNCT00527943What this trial is testingTrial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Particpants With Acute Coronary Syndrome (TRA•CER) (Study P04736)Who this might be right forAtherosclerosisMyocardial IschemiaMyocardial Infarction Merck Sharp & Dohme LLC 12,944
Early research (Phase 1)Temporarily pausedNCT04891913What this trial is testingSY007 in Patients With Acute Ischemic StrokeWho this might be right forAcute Ischemic Stroke Suzhou Yabao Pharmaceutical R&D Co., Ltd. 36
Testing effectiveness (Phase 2)Study completedNCT05403866What this trial is testingEvaluate the Safety and Efficacy of Multiple Doses of LT3001 Drug Product in AIS SubjectsWho this might be right forAcute Ischemic Stroke Lumosa Therapeutics Co., Ltd. 89
Not applicableStudy completedNCT03198715What this trial is testingSafety of DS-1040b in Acute Ischemic Stroke Patients Treated With ThrombectomyWho this might be right forAcute Ischemic Stroke Daiichi Sankyo Co., Ltd. 42
Not applicableStudy completedNCT03551093What this trial is testingTHE IMPACT- 24M TRIAL (IMPlant Augmenting Cerebral Blood Flow in Mild Strokes Trial 24 Hours From Stroke Onset)Who this might be right forIschemic Stroke BrainsGate 50